Format

바카라 보는곳

Choose Destination
카지노 롤링 1995;13(2):94-7.

온라인카지노-코인카지노-스포츠토토﹝opm65.xyz﹞<>➷마카오 룰렛↸필리핀 카지노 앵벌이▥우리카지노총판문의♟라스베가스 카지노♥바카라사이트 쿠폰

온라인카지노-코인카지노-바다 이야기 게임 소스﹝opm65.xyz﹞<>☢바카라 사이트 운영╎무료바둑이↹마카오 카지노 콤프↑카지노 게임 종류▶카지노 룰렛 전략

1
Department of Urology, University of Bochum, Marienhospital, Herne, Germany.

온라인카지노-코인카지노-강원 랜드 앵벌이﹝opm65.xyz﹞<>✯온라인바카라 조작◎해적게임주소➻바카라 영상조작▶세븐 포커 앤 홀덤 apk↰카지노 용어

Laser treatment has become increasingly attractive for treatment of bladder-outlet obstruction due to benign prostatic hyperplasia (BPH). However, it is unknown whether laser treatment may be as effective as transurethral resection of the prostate (TURP), how long effective treatments may last, and whether there may be substantial differences with respect to clinical outcome between different laser treatment modalities currently under clinical investigation. TULIP (transurethral ultrasound-guided laser-induced prostatectomy) was one of the very first laser systems designed for treatment of BPH. The procedure is performed exclusively under transurethral ultrasound guidance, with which the surgeon has to become familiar. However, data reported from single-institution as well as multicenter studies demonstrate that the technique has only a small learning curve. The majority of patients treated by TULIP will experience substantial improvements in subjective and/or objective symptoms, which nevertheless do not appear to be as good as those seen after TURP. This is also shown by data from a prospective and randomized TULIP versus TURP study. However, it has to be emphasized that the clinical significance of such differences remains unknown. Advantageous for TULIP (which may be performed under analgosedation) are reduced blood loss, hospitalization, and rate of postoperative sexual dysfunction. Disadvantageous (as compared with TURP) are the delayed onset of success combined with the prolonged catheterization time and irritative symptoms in the early postoperative phase. In addition, as no tissue is obtained for histology examination, incidental prostate cancer may be missed.

PMID:
7542972
[Indexed for MEDLINE]

온라인카지노-코인카지노-33카지노﹝opm65.xyz﹞<>♧카지노 꽁⇇바카라 썰β온라인 카지노 총판❈마카오 슬롯 머신 게임➹카지노

온라인카지노-코인카지노-해적바둑이게임주소﹝opm65.xyz﹞<>▧바다이야기↺카지노바▩바둑이사이트ω포커 족보╥온라인 카지노 사업

온라인카지노-코인카지노-마카오 환전상﹝opm65.xyz﹞<>⊕카지노 신규가입쿠폰♖인터넷바둑이δ온카 먹튀◐슬롯 사이트☱바둑이

카지노 산업
jnice02-ina17-ad-wb-0280